Dataset Viewer
Auto-converted to Parquet Duplicate
smiles
stringlengths
3
105
problems
stringlengths
291
881
solutions
stringclasses
2 values
id
int64
0
1.07k
Cc1cc(=O)oc2ccc3c(c12)C1(C)OOC1(C)O3
The test checks if a compound causes genetic mutations. For Cc1cc(=O)oc2ccc3c(c12)C1(C)OOC1(C)O3 with features (BCUT2D_MRLOW: -0.59, ATSC2pe: 2.66, BCUT2D_MWHI: 17.29, BCUTse-1h: 3.77, MinAbsPartialCharge: 0.34) and physicochemical (MW 260.24499999999995, logP 2.3870200000000006, TPSA 57.900000000000006, HBD 0, HBA 5, ...
Yes
0
CN(CC(O)CO)N=O
Background: Ames detects mutagenicity. Assess CN(CC(O)CO)N=O with properties — BCUTse-1l=2.59, BCUTdv-1h=6.04, BCUT2D_MRHI=4.54, BCUTse-1h=3.74, BCUTi-1h=14.66 and physicochemical (MW 134.135, logP -1.0472, TPSA 73.13, HBD 2, HBA 4, rotatable bonds 4, Fsp3 1.0, aromatic rings 0, heteroatoms 5, formal charge 0). Output ...
Yes
1
O=[N+]([O-])c1ccc(OC2CO2)cc1
Background: Ames detects mutagenicity. Assess O=[N+]([O-])c1ccc(OC2CO2)cc1 with properties — MinAbsPartialCharge=0.27, BCUT2D_MRHI=5.36, BCUTdv-1h=7.00, BCUTse-1h=3.76, BCUT2D_MWHI=16.76 and physicochemical (MW 181.14699999999996, logP 1.3298999999999999, TPSA 64.9, HBD 0, HBA 4, rotatable bonds 3, Fsp3 0.25, aromatic ...
Yes
2
CC(C)(C)NCC(O)c1cc(Cl)c(N)c(C(F)(F)F)c1
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: CC(C)(C)NCC(O)c1cc(Cl)c(N)c(C(F)(F)F)c1 and properties BCUTdv-1h=7.01, ATSC2pe=6.79, BCUT2D_MWHI=35.50, BCUTi-1h=17.43, MinEStateIndex=-4.61, consider physicochemical proper...
No
3
Cc1ccc2c(ccc3ccccc32)c1
Background: Ames detects mutagenicity. Assess Cc1ccc2c(ccc3ccccc32)c1 with properties — MinEStateIndex=1.31, BCUT2D_MRLOW=1.51, BCUT2D_MWHI=14.03, BCUTi-1h=11.64, BCUTse-1l=2.38 and physicochemical (MW 192.261, logP 4.301420000000003, TPSA 0.0, HBD 0, HBA 0, rotatable bonds 0, Fsp3 0.06666666666666667, aromatic rings 3...
Yes
4
OC[PH](CO)(CO)CO
The test checks if a compound causes genetic mutations. For OC[PH](CO)(CO)CO with features (BCUT2D_MWHI: nan, BCUT2D_MWLOW: nan, MinAbsPartialCharge: nan, BCUTi-1h: 13.63, RPCG: nan) and physicochemical (MW 156.118, logP -1.4645000000000001, TPSA 80.92, HBD 4, HBA 4, rotatable bonds 4, Fsp3 1.0, aromatic rings 0, heter...
No
5
C/C=C/c1ccc(OC)cc1
For C/C=C/c1ccc(OC)cc1 with features BCUTs-1l=1.52, AATSC1c=-0.00, ATSC2pe=-0.30, BCUTse-1l=2.43, BCUTi-1h=13.63 and physicochemical MW 148.20499999999998, logP 2.728300000000001, TPSA 9.23, HBD 0, HBA 1, rotatable bonds 2, Fsp3 0.2, aromatic rings 1, heteroatoms 1, formal charge 0, classify as mutagenic or not. Yes/No...
No
6
c1ccc2c(c1)-c1cc3c(cc1C1NC21)-c1ccccc1C1NC31
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: c1ccc2c(c1)-c1cc3c(cc1C1NC21)-c1ccccc1C1NC31 and properties ATSC2pe=-0.65, BCUTdv-1h=4.25, BCUT2D_MWLOW=9.78, MinEStateIndex=0.50, BalabanJ=1.55, consider physicochemical pr...
Yes
7
COc1nsc2cccc([N+](=O)[O-])c12
Background: Ames detects mutagenicity. Assess COc1nsc2cccc([N+](=O)[O-])c12 with properties — BCUT2D_MWLOW=10.21, AATSC1c=-0.01, BCUT2D_MRHI=7.13, BCUTse-1h=3.76, BCUTi-1h=14.59 and physicochemical (MW 210.21399999999997, logP 2.2131000000000007, TPSA 65.26, HBD 0, HBA 5, rotatable bonds 2, Fsp3 0.125, aromatic rings 2...
Yes
8
CC(C)=CCC1CCCC1=O
For CC(C)=CCC1CCCC1=O with features BCUTs-1l=1.23, RPCG=0.20, AATSC1c=-0.00, BCUT2D_MWHI=16.14, BCUTi-1h=13.64 and physicochemical MW 152.237, logP 2.711900000000001, TPSA 17.07, HBD 0, HBA 1, rotatable bonds 2, Fsp3 0.7, aromatic rings 0, heteroatoms 1, formal charge 0, classify as mutagenic or not. Yes/No.
No
9
CCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCC
The test checks if a compound causes genetic mutations. For CCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCC with features (BCUT2D_MWLOW: 10.07, AATSC1c: -0.01, BCUTse-1h: 3.72, ATSC2pe: 1.26, BCUTi-1h: 13.64) and physicochemical (MW 514.8570000000005, logP 9.428, TPSA 52.60000000000001, HBD 0, HBA 5, rotatable bonds 28, Fsp3...
No
10
CCOC(=O)N(CC)N=O
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: CCOC(=O)N(CC)N=O and properties BCUTs-1l=1.46, BCUTdv-1h=6.04, RPCG=0.42, BCUTse-1h=3.74, BCUTi-1h=14.66, consider physicochemical properties (MW 146.146, logP 1.1462, TPSA ...
Yes
11
CCCCCCN(N=O)C(N)=O
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: CCCCCCN(N=O)C(N)=O and properties MinAbsPartialCharge=0.34, BCUTdv-1h=6.04, BCUTs-1l=1.32, BCUTse-1h=3.74, BCUTi-1h=14.66, consider physicochemical properties (MW 173.216, l...
Yes
12
O=C(C(=O)c1ccccc1)c1ccccc1
The test checks if a compound causes genetic mutations. For O=C(C(=O)c1ccccc1)c1ccccc1 with features (VSA_EState5: -0.93, MinAbsPartialCharge: 0.23, BCUT2D_MRHI: 6.49, BCUTse-1l: 2.44, BCUTi-1h: 13.64) and physicochemical (MW 210.232, logP 2.752200000000001, TPSA 34.14, HBD 0, HBA 2, rotatable bonds 3, Fsp3 0.0, aromat...
No
13
Cc1ccccc1OCC1CO1
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: Cc1ccccc1OCC1CO1 and properties BalabanJ=1.96, BCUTse-1l=2.44, ATSC2pe=-0.85, BCUTs-1l=1.25, BCUT2D_MWHI=16.60, consider physicochemical properties (MW 164.20399999999998, l...
Yes
14
Oc1c(Cl)cccc1Cl
Background: Ames detects mutagenicity. Assess Oc1c(Cl)cccc1Cl with properties — BCUT2D_MWHI=35.50, BCUT2D_MRLOW=0.48, BCUTs-1l=1.29, BCUTse-1l=2.44, BCUTi-1h=13.62 and physicochemical (MW 163.003, logP 2.699, TPSA 20.23, HBD 1, HBA 1, rotatable bonds 0, Fsp3 0.0, aromatic rings 1, heteroatoms 3, formal charge 0). Outpu...
No
15
Nc1ccccc1SCSc1ccccc1N
For Nc1ccccc1SCSc1ccccc1N with features qed=0.50, RPCG=0.11, MaxAbsPartialCharge=0.40, BCUTi-1h=14.54, MinEStateIndex=0.83 and physicochemical MW 262.403, logP 3.6929000000000016, TPSA 52.04, HBD 2, HBA 4, rotatable bonds 4, Fsp3 0.07692307692307693, aromatic rings 2, heteroatoms 4, formal charge 0, classify as mutagen...
Yes
16
Cc1ccncc1
For Cc1ccncc1 with features BCUTs-1l=1.53, BCUTse-1l=2.46, AATSC1c=-0.00, BCUT2D_MWHI=14.60, BCUT2D_MRHI=5.05 and physicochemical MW 93.12899999999999, logP 1.39002, TPSA 12.89, HBD 0, HBA 1, rotatable bonds 0, Fsp3 0.16666666666666666, aromatic rings 1, heteroatoms 1, formal charge 0, classify as mutagenic or not. Yes...
No
17
CC(=O)Oc1ccc2c(c1)OC1(C)OOC21C
For CC(=O)Oc1ccc2c(c1)OC1(C)OOC21C with features BCUTse-1l=2.44, ATSC2pe=2.66, BCUT2D_MWHI=17.29, BCUTse-1h=3.77, BCUT2D_MWLOW=9.89 and physicochemical MW 236.22299999999996, logP 1.8974999999999997, TPSA 53.99000000000001, HBD 0, HBA 5, rotatable bonds 1, Fsp3 0.4166666666666667, aromatic rings 1, heteroatoms 5, forma...
Yes
18
Nc1ccc2c(c1)Cc1cc([N+](=O)[O-])ccc1-2
The test checks if a compound causes genetic mutations. For Nc1ccc2c(c1)Cc1cc([N+](=O)[O-])ccc1-2 with features (AATSC1c: -0.01, MaxAbsPartialCharge: 0.40, BCUT2D_MWHI: 16.63, BCUTse-1h: 3.76, BCUTi-1h: 14.59) and physicochemical (MW 226.235, logP 2.7482000000000006, TPSA 69.16, HBD 1, HBA 3, rotatable bonds 1, Fsp3 0....
Yes
19
c1ccc2c(c1)-c1ccc3ccccc3c1C1NC21
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: c1ccc2c(c1)-c1ccc3ccccc3c1C1NC21 and properties BCUT2D_MWHI=15.15, BalabanJ=1.94, MinEStateIndex=0.51, BCUTdv-1h=4.28, BCUT2D_MWLOW=9.83, consider physicochemical properties...
Yes
20
Cc1ccc2ccccc2c1[N+](=O)[O-]
For Cc1ccc2ccccc2c1[N+](=O)[O-] with features BCUTdv-1h=7.00, BCUTs-1l=1.38, BCUT2D_MWHI=16.63, BalabanJ=2.90, BCUTse-1h=3.76 and physicochemical MW 187.19799999999998, logP 3.056420000000002, TPSA 43.14, HBD 0, HBA 2, rotatable bonds 1, Fsp3 0.09090909090909091, aromatic rings 2, heteroatoms 3, formal charge 0, classi...
Yes
21
CC(C)(C)c1ccc(OC[C@H]2CO2)cc1
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: CC(C)(C)c1ccc(OC[C@H]2CO2)cc1 and properties BCUT2D_MWLOW=9.87, BalabanJ=1.96, BCUTi-1h=13.63, ATSC2pe=-0.40, BCUT2D_MWHI=16.60, consider physicochemical properties (MW 206....
Yes
22
COc1ccc(CNC(=O)C(C)Br)cc1
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: COc1ccc(CNC(=O)C(C)Br)cc1 and properties BCUTs-1l=1.02, qed=0.85, RPCG=0.16, BCUT2D_MWHI=79.92, ATSC2pe=-0.07, consider physicochemical properties (MW 272.142, logP 2.094799...
Yes
23
ClCc1cccc(CCl)c1
Background: Ames detects mutagenicity. Assess ClCc1cccc(CCl)c1 with properties — BCUT2D_MRLOW=1.32, BCUTse-1l=2.44, BCUTs-1h=2.25, AATSC1c=-0.00, BCUTi-1h=12.98 and physicochemical (MW 175.058, logP 3.164200000000002, TPSA 0.0, HBD 0, HBA 0, rotatable bonds 2, Fsp3 0.25, aromatic rings 1, heteroatoms 2, formal charge 0...
No
24
CC1=CC[C@H]2C[C@@H]1C2(C)C
Background: Ames detects mutagenicity. Assess CC1=CC[C@H]2C[C@@H]1C2(C)C with properties — BCUTdv-1h=4.06, ATSC2pe=0.22, BCUT2D_MRHI=5.21, BCUT2D_MWHI=14.54, BCUTi-1h=11.55 and physicochemical (MW 136.238, logP 2.9987000000000013, TPSA 0.0, HBD 0, HBA 0, rotatable bonds 0, Fsp3 0.8, aromatic rings 0, heteroatoms 0, for...
No
25
O=[N+]([O-])c1c2c(c3ccc4cccc5ccc1c3c45)CCC=C2
The test checks if a compound causes genetic mutations. For O=[N+]([O-])c1c2c(c3ccc4cccc5ccc1c3c45)CCC=C2 with features (MaxAbsPartialCharge: 0.28, BCUTse-1h: 3.76, BCUT2D_MWHI: 16.63, BCUT2D_MRHI: 6.26, BCUTse-1l: 2.37) and physicochemical (MW 299.32900000000006, logP 5.451600000000003, TPSA 43.14, HBD 0, HBA 2, rotat...
Yes
26
CCCCN(N=O)/C(C=O)=N/O
For CCCCN(N=O)/C(C=O)=N/O with features qed=0.17, MaxAbsPartialCharge=0.41, BCUT2D_MRHI=6.26, BCUTse-1h=3.74, BCUTi-1h=14.66 and physicochemical MW 173.172, logP 0.7565000000000002, TPSA 82.33, HBD 1, HBA 5, rotatable bonds 5, Fsp3 0.6666666666666666, aromatic rings 0, heteroatoms 6, formal charge 0, classify as mutage...
Yes
27
Cc1ccc(NN=NCc2ccccc2)cc1
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: Cc1ccc(NN=NCc2ccccc2)cc1 and properties BCUTs-1l=1.43, BCUTse-1l=2.44, MinEStateIndex=0.60, AATSC1c=-0.00, BCUTi-1h=14.76, consider physicochemical properties (MW 225.295000...
Yes
28
CN(C)NC(=O)CCC(=O)O
The test checks if a compound causes genetic mutations. For CN(C)NC(=O)CCC(=O)O with features (BCUT2D_MWLOW: 10.29, MaxAbsPartialCharge: 0.48, BCUTs-1l: 1.37, ATSC2pe: 1.02, BCUTi-1h: 14.64) and physicochemical (MW 160.173, logP -0.556, TPSA 69.64, HBD 2, HBA 3, rotatable bonds 4, Fsp3 0.6666666666666666, aromatic ring...
No
29
Cc1c2ccccc2c(CO)c2ccccc12
Background: Ames detects mutagenicity. Assess Cc1c2ccccc2c(CO)c2ccccc12 with properties — BCUT2D_MWLOW=9.93, BCUTdv-1h=5.00, RPCG=0.21, BCUTi-1h=13.62, BCUTse-1l=2.38 and physicochemical (MW 222.28699999999998, logP 3.793720000000002, TPSA 20.23, HBD 1, HBA 1, rotatable bonds 1, Fsp3 0.125, aromatic rings 3, heteroatom...
Yes
30
CC(=O)c1ccccc1
For CC(=O)c1ccccc1 with features BCUT2D_MWLOW=10.15, BalabanJ=2.98, BCUTse-1l=2.44, BCUT2D_MWHI=16.14, BCUTi-1h=13.64 and physicochemical MW 120.15099999999995, logP 1.8892, TPSA 17.07, HBD 0, HBA 1, rotatable bonds 1, Fsp3 0.125, aromatic rings 1, heteroatoms 1, formal charge 0, classify as mutagenic or not. Yes/No.
No
31
CN(C)CCOC(c1ccccc1)c1ccccc1
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: CN(C)CCOC(c1ccccc1)c1ccccc1 and properties AATSC1c=-0.00, BCUTs-1l=1.27, qed=0.78, BCUTse-1l=2.43, BCUT2D_MRHI=5.29, consider physicochemical properties (MW 255.361000000000...
No
32
O=[N+]([O-])c1ccc2ccc3cc4c(c5ccc1c2c35)C(O)C(O)C=C4
Background: Ames detects mutagenicity. Assess O=[N+]([O-])c1ccc2ccc3cc4c(c5ccc1c2c35)C(O)C(O)C=C4 with properties — AATSC1c=-0.01, MinEStateIndex=-1.01, BCUT2D_MWHI=16.63, BCUT2D_MRHI=6.25, BCUTse-1l=2.37 and physicochemical (MW 331.327, logP 3.913300000000002, TPSA 83.60000000000001, HBD 2, HBA 4, rotatable bonds 1, F...
Yes
33
O=[N+]([O-])C(Cl)(Cl)Cl
The test checks if a compound causes genetic mutations. For O=[N+]([O-])C(Cl)(Cl)Cl with features (RPCG: 0.85, BCUTi-1h: 14.59, BCUT2D_MRHI: 6.65, BCUTse-1h: 3.76, AvgIpc: 1.31) and physicochemical (MW 164.37500000000003, logP 1.5908, TPSA 43.14, HBD 0, HBA 2, rotatable bonds 0, Fsp3 1.0, aromatic rings 0, heteroatoms ...
Yes
34
COC[C@@H](O)Cn1cc([N+](=O)[O-])nc1Cl
For COC[C@@H](O)Cn1cc([N+](=O)[O-])nc1Cl with features ATSC2pe=-0.42, BCUT2D_MRHI=6.28, BCUT2D_MWHI=35.50, BCUTse-1h=3.76, BCUTi-1h=14.60 and physicochemical MW 235.627, logP 0.452, TPSA 90.42, HBD 1, HBA 6, rotatable bonds 5, Fsp3 0.5714285714285714, aromatic rings 1, heteroatoms 8, formal charge 0, classify as mutage...
Yes
35
O=[N+]([O-])c1ccc(I)c([N+](=O)[O-])c1
The test checks if a compound causes genetic mutations. For O=[N+]([O-])c1ccc(I)c([N+](=O)[O-])c1 with features (BCUTdv-1h: 7.01, MaxAbsPartialCharge: 0.29, BCUTse-1l: 2.44, BCUTse-1h: 3.76, BCUTi-1h: 14.60) and physicochemical (MW 294.004, logP 2.1076, TPSA 86.28, HBD 0, HBA 4, rotatable bonds 2, Fsp3 0.0, aromatic ri...
Yes
36
O=[N+]([O-])c1ccc2c(c1)Oc1ccc([N+](=O)[O-])cc1O2
Background: Ames detects mutagenicity. Assess O=[N+]([O-])c1ccc2c(c1)Oc1ccc([N+](=O)[O-])cc1O2 with properties — BCUTdv-1h=7.01, BCUT2D_MWLOW=10.20, BCUTse-1l=2.44, BCUTi-1h=14.60, BCUT2D_MWHI=16.63 and physicochemical (MW 274.188, logP 3.4010000000000016, TPSA 104.74000000000001, HBD 0, HBA 6, rotatable bonds 2, Fsp3 ...
Yes
37
CC1CCCC(O)CCCCCc2cc(O)cc(O)c2C(=O)O1
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: CC1CCCC(O)CCCCCc2cc(O)cc(O)c2C(=O)O1 and properties BCUTs-1l=1.24, MaxAbsPartialCharge=0.51, ATSC2pe=1.19, BCUTi-1h=13.64, MinAbsPartialCharge=0.34, consider physicochemical...
No
38
Cc1cc2ccccc2c2ccc3c(c12)C=CC(=O)C3=O
Background: Ames detects mutagenicity. Assess Cc1cc2ccccc2c2ccc3c(c12)C=CC(=O)C3=O with properties — MinAbsPartialCharge=0.23, MaxAbsPartialCharge=0.29, BCUTi-1h=13.64, BCUT2D_MWLOW=9.87, BCUTse-1l=2.38 and physicochemical (MW 272.303, logP 4.080020000000003, TPSA 34.14, HBD 0, HBA 2, rotatable bonds 0, Fsp3 0.05263157...
Yes
39
CC(C)(C)OOC(C)(C)CCC(C)(C)OOC(C)(C)C
Background: Ames detects mutagenicity. Assess CC(C)(C)OOC(C)(C)CCC(C)(C)OOC(C)(C)C with properties — BCUT2D_MWLOW=9.94, BCUT2D_MRHI=4.75, BCUTdv-1h=6.11, BCUT2D_MWHI=17.22, BCUTse-1h=3.77 and physicochemical (MW 290.444, logP 4.817200000000005, TPSA 36.92, HBD 0, HBA 4, rotatable bonds 7, Fsp3 1.0, aromatic rings 0, he...
No
40
C=CC(C)(C)c1cc2cc3c(cc2oc1=O)OC(C(C)(C)O)C3
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: C=CC(C)(C)c1cc2cc3c(cc2oc1=O)OC(C(C)(C)O)C3 and properties BCUTdv-1h=6.04, ATSC2pe=2.19, BalabanJ=2.13, BCUTse-1h=3.73, MaxAbsPartialCharge=0.49, consider physicochemical pr...
Yes
41
Nc1ccc(N=Nc2cccc(N=Nc3ccc(N)cc3N)c2)c(N)c1
The test checks if a compound causes genetic mutations. For Nc1ccc(N=Nc2cccc(N=Nc3ccc(N)cc3N)c2)c(N)c1 with features (BCUTse-1l: 2.44, MaxAbsPartialCharge: 0.40, BCUT2D_MWHI: 15.13, BCUTi-1h: 14.74, RPCG: 0.06) and physicochemical (MW 346.39800000000014, logP 4.846200000000002, TPSA 153.51999999999998, HBD 4, HBA 8, ro...
Yes
42
OC(Cn1ccnc1)c1ccc(CCc2ccccc2)cc1
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: OC(Cn1ccnc1)c1ccc(CCc2ccccc2)cc1 and properties BCUTse-1l=2.43, BCUTdv-1h=5.04, BCUTs-1l=1.26, BCUT2D_MRHI=5.25, BalabanJ=1.58, consider physicochemical properties (MW 292.3...
No
43
O=C(O)c1ccccc1Nc1cc(Cl)ccc1C(=O)O
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: O=C(O)c1ccccc1Nc1cc(Cl)ccc1C(=O)O and properties BCUT2D_MWHI=35.50, BCUTse-1l=2.43, ATSC2pe=1.50, BCUTs-1l=1.30, MinAbsPartialCharge=0.34, consider physicochemical propertie...
No
44
CC1CS(=O)(=O)CCN1N=Cc1ccc([N+](=O)[O-])o1
Background: Ames detects mutagenicity. Assess CC1CS(=O)(=O)CCN1N=Cc1ccc([N+](=O)[O-])o1 with properties — MinEStateIndex=-2.98, BCUTse-1h=3.77, ATSC2pe=1.86, BCUT2D_MWHI=32.23, BCUTi-1h=14.64 and physicochemical (MW 287.297, logP 0.6406000000000001, TPSA 106.02, HBD 0, HBA 7, rotatable bonds 3, Fsp3 0.5, aromatic rings...
Yes
45
O=[N+]([O-])c1ccc(C2OCC3(CO)COC(c4ccc([N+](=O)[O-])cc4)N23)cc1
Background: Ames detects mutagenicity. Assess O=[N+]([O-])c1ccc(C2OCC3(CO)COC(c4ccc([N+](=O)[O-])cc4)N23)cc1 with properties — MaxAbsPartialCharge=0.39, BCUTdv-1h=7.01, BCUT2D_MWHI=16.63, BalabanJ=1.67, BCUTi-1h=14.60 and physicochemical (MW 387.348, logP 2.2939, TPSA 128.21000000000004, HBD 1, HBA 8, rotatable bonds 5...
Yes
46
CCOP(=S)(OCC(C)C)SCCl
For CCOP(=S)(OCC(C)C)SCCl with features BCUT2D_MWHI=35.50, BCUT2D_MWLOW=10.25, BalabanJ=3.99, MinAbsPartialCharge=0.25, BCUTi-1h=13.63 and physicochemical MW 262.764, logP 3.8495000000000035, TPSA 18.46, HBD 0, HBA 4, rotatable bonds 7, Fsp3 1.0, aromatic rings 0, heteroatoms 6, formal charge 0, classify as mutagenic o...
No
47
CNC1=C2CC(=O)C(OC)=CC=C2c2c(cc(OC)c(OC)c2OC)CC1
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: CNC1=C2CC(=O)C(OC)=CC=C2c2c(cc(OC)c(OC)c2OC)CC1 and properties BCUT2D_MWLOW=9.91, qed=0.86, ATSC2pe=-1.75, VSA_EState5=2.07, RPCG=0.07, consider physicochemical properties (...
No
48
CC(=O)ON(OCc1ccc(Br)cc1)C(=O)c1ccccc1
For CC(=O)ON(OCc1ccc(Br)cc1)C(=O)c1ccccc1 with features MaxAbsPartialCharge=0.33, BCUT2D_MWLOW=10.20, ATSC2pe=1.93, BCUTdv-1h=6.03, BCUTse-1l=2.44 and physicochemical MW 364.1950000000001, logP 3.5012000000000025, TPSA 55.839999999999996, HBD 0, HBA 4, rotatable bonds 4, Fsp3 0.125, aromatic rings 2, heteroatoms 6, for...
Yes
49
c1ccc2cc3c(cc2c1)-c1cccc2cccc-3c12
The test checks if a compound causes genetic mutations. For c1ccc2cc3c(cc2c1)-c1cccc2cccc-3c12 with features (BCUT2D_MRHI: 6.17, RPCG: 0.08, BCUT2D_MRLOW: 1.73, BCUTi-1h: 11.64, BCUTse-1l: 2.40) and physicochemical (MW 252.31599999999997, logP 5.640400000000003, TPSA 0.0, HBD 0, HBA 0, rotatable bonds 0, Fsp3 0.0, arom...
Yes
50
O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23
For O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23 with features BCUTs-1l=1.32, AATSC1c=-0.04, MaxAbsPartialCharge=0.50, BCUTse-1l=2.38, MinAbsPartialCharge=0.34 and physicochemical MW 302.194, logP 1.3127999999999997, TPSA 141.34, HBD 4, HBA 8, rotatable bonds 0, Fsp3 0.0, aromatic rings 4, heteroatoms 8, formal charge 0,...
No
51
ClC(Cl)(Cl)[C@@H]1CO1
The test checks if a compound causes genetic mutations. For ClC(Cl)(Cl)[C@@H]1CO1 with features (BCUTse-1h: 3.68, BCUTs-1l: 1.07, BCUT2D_MRHI: 6.68, BCUTi-1h: 13.63, BCUT2D_MWHI: 35.58) and physicochemical (MW 161.415, logP 1.7553999999999998, TPSA 12.53, HBD 0, HBA 1, rotatable bonds 0, Fsp3 1.0, aromatic rings 0, het...
Yes
52
COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC
Background: Ames detects mutagenicity. Assess COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC with properties — BCUT2D_MRHI=5.55, VSA_EState5=2.23, BCUTse-1l=2.44, ATSC2pe=-0.31, qed=0.85 and physicochemical (MW 290.32300000000004, logP 1.2575999999999998, TPSA 105.51, HBD 2, HBA 7, rotatable bonds 5, Fsp3 0.2857142857142857, aromatic...
No
53
CN1C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12
For CN1C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12 with features BCUTse-1l=2.44, BCUT2D_MWLOW=9.97, BalabanJ=1.42, ATSC2pe=-0.60, BCUT2D_MWHI=16.61 and physicochemical MW 303.358, logP 0.9180999999999995, TPSA 62.3, HBD 1, HBA 5, rotatable bonds 4, Fsp3 0.5882352941176471, aromatic rings 1, heteroatoms 5, formal charge 0, class...
No
54
CCCCSCCC(N)C(=O)O
The test checks if a compound causes genetic mutations. For CCCCSCCC(N)C(=O)O with features (BCUT2D_MWHI: 32.17, BCUT2D_MWLOW: 10.24, MaxAbsPartialCharge: 0.48, BCUTse-1h: 3.71, ATSC2pe: 1.06) and physicochemical (MW 191.296, logP 1.3216999999999999, TPSA 63.32000000000001, HBD 2, HBA 3, rotatable bonds 7, Fsp3 0.875, ...
No
55
Clc1cc(Cl)c(Cl)c(Cl)c1Cl
For Clc1cc(Cl)c(Cl)c(Cl)c1Cl with features BCUTs-1h=2.12, AATSC1c=-0.00, BCUTs-1l=1.26, BCUTse-1l=2.44, BCUTi-1h=12.98 and physicochemical MW 250.339, logP 4.9536, TPSA 0.0, HBD 0, HBA 0, rotatable bonds 0, Fsp3 0.0, aromatic rings 1, heteroatoms 5, formal charge 0, classify as mutagenic or not. Yes/No.
No
56
CC(N)C(O)c1ccccc1
The test checks if a compound causes genetic mutations. For CC(N)C(O)c1ccccc1 with features (qed: 0.66, ATSC2pe: -0.14, BCUTse-1l: 2.44, BCUTdv-1h: 5.01, BCUT2D_MRHI: 5.18) and physicochemical (MW 151.20899999999997, logP 1.0672000000000001, TPSA 46.25, HBD 2, HBA 2, rotatable bonds 2, Fsp3 0.3333333333333333, aromatic...
No
57
Clc1ccccc1
The test checks if a compound causes genetic mutations. For Clc1ccccc1 with features (ATSC2pe: -0.05, BCUTs-1l: 1.30, AATSC1c: -0.00, BCUTse-1l: 2.45, BCUTi-1h: 12.97) and physicochemical (MW 112.55899999999997, logP 2.34, TPSA 0.0, HBD 0, HBA 0, rotatable bonds 0, Fsp3 0.0, aromatic rings 1, heteroatoms 1, formal char...
No
58
CCCCN(N)CCCC
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: CCCCN(N)CCCC and properties BCUTi-1l=11.09, MinEStateIndex=1.05, BCUT2D_MWHI=15.39, BCUT2D_MRHI=4.47, BCUTi-1h=14.65, consider physicochemical properties (MW 144.262, logP 1...
No
59
O=C(O)CCCOc1ccc(Cl)cc1Cl
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: O=C(O)CCCOc1ccc(Cl)cc1Cl and properties BCUTse-1h=3.71, BCUT2D_MWHI=35.50, BCUTse-1l=2.44, BCUTi-1h=13.64, BCUTs-1l=1.30, consider physicochemical properties (MW 249.0930000...
No
60
Cc1cccc(C(=O)O)c1[N+](=O)[O-]
For Cc1cccc(C(=O)O)c1[N+](=O)[O-] with features BCUTdv-1h=7.00, MinEStateIndex=-1.28, BCUT2D_MWHI=16.63, MinAbsPartialCharge=0.34, BCUTse-1h=3.76 and physicochemical MW 181.147, logP 1.60142, TPSA 80.44, HBD 1, HBA 3, rotatable bonds 2, Fsp3 0.125, aromatic rings 1, heteroatoms 5, formal charge 0, classify as mutagenic...
Yes
61
CCCC=O
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: CCCC=O and properties BCUTse-1l=2.57, AvgIpc=1.41, BCUTse-1h=3.70, BCUT2D_MWHI=16.13, BCUTi-1h=13.64, consider physicochemical properties (MW 72.107, logP 0.9854, TPSA 17.07...
No
62
O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCO)ccc(NCCO)c21
For O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCO)ccc(NCCO)c21 with features BCUTs-1l=1.36, BalabanJ=2.26, MaxAbsPartialCharge=0.51, BCUT2D_MWLOW=9.81, ATSC2pe=-1.44 and physicochemical MW 358.3500000000001, logP 0.6816, TPSA 139.12, HBD 6, HBA 8, rotatable bonds 6, Fsp3 0.2222222222222222, aromatic rings 2, heteroatoms 8, formal ch...
Yes
63
CC(=O)Nc1ccc2c3c(cccc13)-c1cc(O)ccc1-2
The test checks if a compound causes genetic mutations. For CC(=O)Nc1ccc2c3c(cccc13)-c1cc(O)ccc1-2 with features (RPCG: 0.20, BCUTse-1h: 3.70, MaxAbsPartialCharge: 0.51, BCUT2D_MRHI: 6.19, BCUTse-1l: 2.40) and physicochemical (MW 275.307, logP 4.151200000000002, TPSA 49.33, HBD 2, HBA 2, rotatable bonds 1, Fsp3 0.05555...
Yes
64
CC(=O)Cl
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: CC(=O)Cl and properties BCUT2D_MWHI=35.50, MATS2pe=0.50, BCUTi-1h=13.64, AvgIpc=0.81, BCUTs-1l=1.31, consider physicochemical properties (MW 78.498, logP 0.7717, TPSA 17.07,...
No
65
O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1C(F)(F)F
Background: Ames detects mutagenicity. Assess O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1C(F)(F)F with properties — BalabanJ=2.43, BCUTdv-1h=7.01, BCUT2D_MWHI=19.41, MinEStateIndex=-4.92, BCUTi-1h=17.43 and physicochemical (MW 296.20099999999996, logP -0.8039000000000001, TPSA 104.55000000000001, HBD 3, HBA 6, rotatable bonds 2,...
Yes
66
CCCCCl
Background: Ames detects mutagenicity. Assess CCCCCl with properties — MaxAbsPartialCharge=0.13, BCUT2D_MWHI=35.50, BCUT2D_MRHI=6.17, BCUTs-1l=1.27, BCUTi-1h=12.97 and physicochemical (MW 92.56899999999999, logP 2.0253, TPSA 0.0, HBD 0, HBA 0, rotatable bonds 2, Fsp3 1.0, aromatic rings 0, heteroatoms 1, formal charge ...
No
67
COc1ccc2c(CBr)cc(=O)oc2c1
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: COc1ccc2c(CBr)cc(=O)oc2c1 and properties VSA_EState5=0.68, qed=0.62, MinAbsPartialCharge=0.34, BCUT2D_MWLOW=10.13, MaxAbsPartialCharge=0.50, consider physicochemical propert...
No
68
c1ccc(OCC2CO2)cc1
Background: Ames detects mutagenicity. Assess c1ccc(OCC2CO2)cc1 with properties — BalabanJ=1.85, MATS2pe=-0.26, ATSC2pe=-1.14, BCUTs-1l=1.25, BCUT2D_MWHI=16.60 and physicochemical (MW 150.177, logP 1.4641999999999997, TPSA 21.759999999999998, HBD 0, HBA 2, rotatable bonds 3, Fsp3 0.3333333333333333, aromatic rings 1, h...
Yes
69
C=C(C)C(=O)OCCC
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: C=C(C)C(=O)OCCC and properties BCUTs-1l=1.39, BCUTse-1h=3.71, ATSC2pe=1.07, MinAbsPartialCharge=0.33, BCUTi-1h=13.64, consider physicochemical properties (MW 128.17099999999...
No
70
CSCC(NC(=O)C(C)(C)SC)C(=O)O
The test checks if a compound causes genetic mutations. For CSCC(NC(=O)C(C)(C)SC)C(=O)O with features (VSA_EState5: -0.85, MinAbsPartialCharge: 0.33, BCUT2D_MWHI: 32.17, ATSC2pe: 2.22, BCUT2D_MWLOW: 10.15) and physicochemical (MW 251.373, logP 1.0603999999999998, TPSA 66.4, HBD 2, HBA 4, rotatable bonds 6, Fsp3 0.77777...
No
71
CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC
For CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC with features BCUTs-1l=1.22, BCUT2D_MWLOW=10.00, BCUTse-1h=3.72, ATSC2pe=1.65, BCUTi-1h=13.64 and physicochemical MW 426.68200000000024, logP 7.626400000000009, TPSA 52.60000000000001, HBD 0, HBA 4, rotatable bonds 21, Fsp3 0.9230769230769231, aromatic rings 0, heteroatoms 4...
No
72
C=CC(=O)OCC(C)(C)C
For C=CC(=O)OCC(C)(C)C with features MinEStateIndex=-0.35, MinAbsPartialCharge=0.33, BCUTse-1h=3.71, ATSC2pe=1.23, BCUTi-1h=13.64 and physicochemical MW 142.19799999999998, logP 1.7616999999999998, TPSA 26.3, HBD 0, HBA 2, rotatable bonds 2, Fsp3 0.625, aromatic rings 0, heteroatoms 2, formal charge 0, classify as muta...
No
73
O=C(Cl)c1cccc([N+](=O)[O-])c1
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: O=C(Cl)c1cccc([N+](=O)[O-])c1 and properties MaxAbsPartialCharge=0.28, BCUT2D_MRHI=6.67, BCUTse-1l=2.44, AATSC1c=-0.00, BCUTse-1h=3.76, consider physicochemical properties (...
Yes
74
C=Cc1ccccc1Cl
For C=Cc1ccccc1Cl with features BCUTs-1l=1.30, AATSC1c=-0.00, BCUTse-1l=2.43, BCUT2D_MWLOW=10.21, BCUTi-1h=12.97 and physicochemical MW 138.59699999999998, logP 2.9830000000000014, TPSA 0.0, HBD 0, HBA 0, rotatable bonds 1, Fsp3 0.0, aromatic rings 1, heteroatoms 1, formal charge 0, classify as mutagenic or not. Yes/No...
No
75
Cc1cnc(S)nc1O
For Cc1cnc(S)nc1O with features BalabanJ=3.17, BCUT2D_MRHI=7.80, BCUT2D_MWLOW=10.38, MinEStateIndex=-0.00, BCUTse-1l=2.49 and physicochemical MW 142.18300000000002, logP 0.7793199999999998, TPSA 46.010000000000005, HBD 2, HBA 4, rotatable bonds 0, Fsp3 0.2, aromatic rings 1, heteroatoms 4, formal charge 0, classify as ...
No
76
CCOC(=O)C[C@H](S[P@@](=O)(OC)SC)C(=O)OCC
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: CCOC(=O)C[C@H](S[P@@](=O)(OC)SC)C(=O)OCC and properties BCUTse-1l=2.43, BCUT2D_MWHI=33.10, MinAbsPartialCharge=0.32, ATSC2pe=2.21, BCUTi-1h=13.65, consider physicochemical p...
No
77
O=C1CN(/N=C/C=C/c2ccc([N+](=O)[O-])o2)C(=O)N1
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: O=C1CN(/N=C/C=C/c2ccc([N+](=O)[O-])o2)C(=O)N1 and properties AATSC1c=-0.02, BCUTs-1l=1.43, BCUT2D_MWHI=16.65, BCUTse-1h=3.76, BCUTi-1h=14.64, consider physicochemical proper...
Yes
78
O=C(OCc1ccccc1)c1ccccc1O
For O=C(OCc1ccccc1)c1ccccc1O with features BCUTse-1l=2.44, BCUT2D_MWLOW=10.18, BCUTs-1l=1.43, MinAbsPartialCharge=0.34, BCUTi-1h=13.64 and physicochemical MW 228.24699999999999, logP 2.7492000000000014, TPSA 46.53, HBD 1, HBA 3, rotatable bonds 3, Fsp3 0.07142857142857142, aromatic rings 2, heteroatoms 3, formal charge...
No
79
O=[N+]([O-])c1ccc2c[nH]nc2c1
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: O=[N+]([O-])c1ccc2c[nH]nc2c1 and properties BCUTdv-1h=7.00, MaxAbsPartialCharge=0.28, BCUT2D_MWHI=16.63, BCUTse-1h=3.76, BCUTi-1h=14.69, consider physicochemical properties ...
Yes
80
O=C1CCc2c1ccc1c2ccc2ccccc21
For O=C1CCc2c1ccc1c2ccc2ccccc21 with features BCUT2D_MRHI=6.13, RPCG=0.19, BCUT2D_MWHI=16.14, BCUTi-1h=13.64, BCUTse-1l=2.38 and physicochemical MW 232.282, logP 4.121900000000003, TPSA 17.07, HBD 0, HBA 1, rotatable bonds 0, Fsp3 0.11764705882352941, aromatic rings 3, heteroatoms 1, formal charge 0, classify as mutage...
Yes
81
O=C(O)c1ccc(/C=C/c2ccc([N+](=O)[O-])o2)cc1
For O=C(O)c1ccc(/C=C/c2ccc([N+](=O)[O-])o2)cc1 with features BCUTdv-1h=7.00, BCUTse-1h=3.76, BCUT2D_MWHI=16.65, BCUT2D_MWLOW=10.12, BCUTi-1h=14.59 and physicochemical MW 259.217, logP 3.056400000000001, TPSA 93.58, HBD 1, HBA 4, rotatable bonds 4, Fsp3 0.0, aromatic rings 2, heteroatoms 6, formal charge 0, classify as ...
Yes
82
O=C(/N=c1\sn(C(=O)c2ccccc2[N+](=O)[O-])c2ccc([N+](=O)[O-])cc12)c1ccccc1[N+](=O)[O-]
The test checks if a compound causes genetic mutations. For O=C(/N=c1\sn(C(=O)c2ccccc2[N+](=O)[O-])c2ccc([N+](=O)[O-])cc12)c1ccccc1[N+](=O)[O-] with features (BCUTse-1h: 3.76, VSA_EState5: -1.82, MaxAbsPartialCharge: 0.28, ATSC2pe: 2.72, BCUTi-1h: 14.60) and physicochemical (MW 493.41300000000024, logP 3.85700000000000...
Yes
83
C[C@H](CCc1ccccc1)NC[C@@H](O)c1ccc(O)c(C(N)=O)c1
Background: Ames detects mutagenicity. Assess C[C@H](CCc1ccccc1)NC[C@@H](O)c1ccc(O)c(C(N)=O)c1 with properties — MinAbsPartialCharge=0.25, BCUTse-1h=3.70, BCUTse-1l=2.43, BCUT2D_MWLOW=10.03, MaxAbsPartialCharge=0.51 and physicochemical (MW 328.4120000000001, logP 2.1353999999999997, TPSA 95.57999999999998, HBD 4, HBA 4...
No
84
CCN(CC)CCn1nc2c3c(c(CO)ccc31)Sc1cc(Cl)ccc1-2
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: CCN(CC)CCn1nc2c3c(c(CO)ccc31)Sc1cc(Cl)ccc1-2 and properties qed=0.52, BCUT2D_MWHI=35.50, BCUT2D_MRHI=7.99, ATSC2pe=-0.50, BCUTi-1h=14.69, consider physicochemical properties...
Yes
85
COC(=O)c1ccccc1N
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: COC(=O)c1ccccc1N and properties MaxAbsPartialCharge=0.47, BCUTse-1h=3.71, BCUTse-1l=2.44, BCUT2D_MWLOW=10.17, MinAbsPartialCharge=0.34, consider physicochemical properties (...
No
86
CC1OC1C
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: CC1OC1C and properties ATSC2pe=-0.12, BCUT2D_MRHI=4.73, BCUT2D_MWHI=16.59, BCUTs-1l=1.22, BCUTi-1h=13.63, consider physicochemical properties (MW 72.107, logP 0.7936, TPSA 1...
Yes
87
Nc1ccc(-c2ccccc2)cc1
The test checks if a compound causes genetic mutations. For Nc1ccc(-c2ccccc2)cc1 with features (RPCG: 0.17, BCUTdv-1h: 4.14, BCUT2D_MRLOW: 1.61, MaxAbsPartialCharge: 0.40, MinEStateIndex: 0.81) and physicochemical (MW 169.227, logP 2.9358000000000013, TPSA 26.02, HBD 1, HBA 1, rotatable bonds 1, Fsp3 0.0, aromatic ring...
Yes
88
C=C1C(=O)O[C@@H]2C[C@@H](C)[C@@H]3C=CC(=O)[C@]3(C)[C@@H](O)[C@H]12
For C=C1C(=O)O[C@@H]2C[C@@H](C)[C@@H]3C=CC(=O)[C@]3(C)[C@@H](O)[C@H]12 with features BalabanJ=2.08, MinAbsPartialCharge=0.33, ATSC2pe=1.10, BCUT2D_MWLOW=9.67, BCUTi-1h=13.64 and physicochemical MW 262.305, logP 1.2462999999999997, TPSA 63.60000000000001, HBD 1, HBA 4, rotatable bonds 0, Fsp3 0.6, aromatic rings 0, hete...
No
89
COC1=CC=CC=CC1
The test checks if a compound causes genetic mutations. For COC1=CC=CC=CC1 with features (MinEStateIndex: 0.91, ATSC2pe: -0.45, BCUTs-1l: 1.42, BCUT2D_MRHI: 5.19, BCUTi-1h: 13.63) and physicochemical (MW 122.16699999999997, logP 2.0328, TPSA 9.23, HBD 0, HBA 1, rotatable bonds 1, Fsp3 0.25, aromatic rings 0, heteroatom...
Yes
90
CC(C)Nc1nc(N)nc(Cl)n1
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: CC(C)Nc1nc(N)nc(Cl)n1 and properties BCUT2D_MWHI=35.50, MinEStateIndex=0.10, RPCG=0.16, ATSC2pe=3.00, BCUTs-1l=1.29, consider physicochemical properties (MW 187.634000000000...
No
91
CCCC[C@@H](CC)COC(=O)CCCCCCCCC(=O)OC[C@H](CC)CCCC
The test checks if a compound causes genetic mutations. For CCCC[C@@H](CC)COC(=O)CCCCCCCCC(=O)OC[C@H](CC)CCCC with features (BCUTs-1l: 1.22, BCUT2D_MWLOW: 10.00, BCUTse-1h: 3.72, ATSC2pe: 1.65, BCUTi-1h: 13.64) and physicochemical (MW 426.68200000000024, logP 7.626400000000009, TPSA 52.60000000000001, HBD 0, HBA 4, rot...
No
92
CCCCC(C)C(OC(=O)CC(CC(=O)O)C(=O)O)C(CC(C)CC(O)CCCCC(O)CC(O)C(C)N)OC(=O)CC(CC(=O)O)C(=O)O
Mutagenicity is the ability of a drug to induce genetic alterations, commonly tested using the (a bacterial reverse mutation assay). Given SMILES: CCCCC(C)C(OC(=O)CC(CC(=O)O)C(=O)O)C(CC(C)CC(O)CCCCC(O)CC(O)C(C)N)OC(=O)CC(CC(=O)O)C(=O)O and properties BCUT2D_MWHI=16.59, MaxAbsPartialCharge=0.48, ATSC2pe=5.84, BCUTse-1h=...
No
93
COP(=O)(OC)OC=C(Cl)Cl
The test checks if a compound causes genetic mutations. For COP(=O)(OC)OC=C(Cl)Cl with features (BalabanJ: 4.10, BCUTse-1h: 3.72, ATSC2pe: 2.67, AATSC1c: -0.04, RPCG: 0.40) and physicochemical (MW 220.976, logP 2.6804000000000006, TPSA 44.760000000000005, HBD 0, HBA 4, rotatable bonds 4, Fsp3 0.5, aromatic rings 0, het...
Yes
94
O=C1CCCCCCCCCCCC(=O)OCCO1
The test checks if a compound causes genetic mutations. For O=C1CCCCCCCCCCCC(=O)OCCO1 with features (RPCG: 0.16, MinEStateIndex: -0.18, BCUTs-1l: 1.31, ATSC2pe: 1.41, BCUTi-1h: 13.64) and physicochemical (MW 270.3689999999999, logP 3.377500000000002, TPSA 52.60000000000001, HBD 0, HBA 4, rotatable bonds 0, Fsp3 0.86666...
No
95
FC(F)(F)c1ccc(CCl)cc1
The test checks if a compound causes genetic mutations. For FC(F)(F)c1ccc(CCl)cc1 with features (ATSC2pe: 5.03, BalabanJ: 2.93, BCUTse-1l: 2.44, BCUTi-1h: 17.43, MinEStateIndex: -4.26) and physicochemical (MW 194.583, logP 3.4442000000000013, TPSA 0.0, HBD 0, HBA 0, rotatable bonds 1, Fsp3 0.25, aromatic rings 1, heter...
No
96
CC(C)(C)c1cc(C=Cc2cc(C(C)(C)C)c(O)c(C(C)(C)C)c2)cc(C(C)(C)C)c1O
The test checks if a compound causes genetic mutations. For CC(C)(C)c1cc(C=Cc2cc(C(C)(C)C)c(O)c(C(C)(C)C)c2)cc(C(C)(C)C)c1O with features (MATS2pe: 0.23, qed: 0.46, BCUTs-1l: 1.18, ATSC2pe: 1.89, BCUTi-1h: 13.62) and physicochemical (MW 436.6800000000002, logP 8.458200000000005, TPSA 40.46, HBD 2, HBA 2, rotatable bond...
No
97
Nc1ccc(O)cc1
The test checks if a compound causes genetic mutations. For Nc1ccc(O)cc1 with features (RPCG: 0.29, BCUTdv-1h: 5.01, qed: 0.38, BCUTse-1l: 2.44, BCUT2D_MRHI: 5.40) and physicochemical (MW 109.12799999999999, logP 0.9743999999999999, TPSA 46.25, HBD 2, HBA 2, rotatable bonds 0, Fsp3 0.0, aromatic rings 1, heteroatoms 2,...
No
98
CC(C)C(=O)Nc1snc2cc(Cl)ccc12
The test checks if a compound causes genetic mutations. For CC(C)C(=O)Nc1snc2cc(Cl)ccc12 with features (MATS2pe: 0.22, BCUT2D_MWHI: 35.50, qed: 0.89, MinEStateIndex: -0.04, ATSC2pe: 1.12) and physicochemical (MW 254.742, logP 3.544200000000002, TPSA 41.99, HBD 1, HBA 3, rotatable bonds 2, Fsp3 0.2727272727272727, aroma...
No
99
End of preview. Expand in Data Studio
README.md exists but content is empty.
Downloads last month
11